Biogen Inc vs Realty Income Corp — how do they compare? Biogen Inc trades at $202.7 (market cap $30.13B), while Realty Income Corp trades at $61.94 (market cap $58.56B). The key difference: Realty Income Corp is the larger of the two by market cap, and Realty Income Corp pays a 5.25% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.
| BIIB | O | |
|---|---|---|
Market Cap | $30.13B | $58.56B |
Sector | Health | Real Estate |
52-Week High | $216.63 | $67.56 |
52-Week Low | $128.93 | $55.93 |
Enterprise Value | $37.20B | $89.19B |
Dividend Yield | — | 5.25% |
Trailing returns across standard periods
Latest headlines on both assets
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Read more on O →